Archive for Pharma & Life Sciences

Pfizer Embraces the Digital Supply Chain

A new head of supply chain at Pfizer asked a simple question, “If Amazon can provide end to end shipment status of my orders, why can’t Pfizer.” That was the impetus for a supply chain visibility project. “The company had to change their mindset and embrace a global orchestrated supply network.

Read More →

New Solutions to Support a Pharmaceutical Value Chain that is in Flux

Leading pharmaceutical and biotech companies must continue to adapt to increasing global competition, regulation, and pricing pressures. In response, the pharmaceutical industry is undergoing a major value chain transformation.

Read More →

A Strategic Approach to Outsourcing European Distribution

I spoke to Tom Doherty, Senior Director Global Supply Chain at Welch Allyn, about the process they used to select a third party logistics (3PL) partner for European distribution.  Welch Allyn, a private company headquartered in Skaneateles Falls New York in the USA, is a leading global manufacturer of medical diagnostic equipment. The company has 2,600 worldwide employees. At the European distribution center (DC) goods, mainly in the form of ocean containers that originate from […]

Read More →

Bolster Your Supply Chain’s Memory in Time for DQSA

In the movie Memento, the main character, Leonard Shelby, relies on tattoos and Polaroid pictures to retrace his past after amnesia wipes out his memory. He needs these details to faithfully reconstruct recent events and resolve the crime that upended his life. While you don’t need tattoos to track pharmaceutical shipments, the passage of House bill H.R. 3204, the Drug Quality and Security Act (DQSA), means track-and-trace requirements for pharmaceuticals have become more precise than […]

Read More →

Leading Healthcare Systems Respond to Obamacare by Making Supply Chain a Critical Differentiator

The health care industry in the US is undergoing transformation driven by the Affordable Care Act (Obamacare) and the increasing impact of consumerism. Healthcare providers historically have had prepaid plans where the cost of care was paid up front and the more procedures a hospital did, the more they got paid. Consequently providers felt little need to practice even the basic tenants of supply chain management or even understand the total cost of particular procedures. […]

Read More →

Apple and Total Landed Profits

Apple’s CEO, Tim Cook, was hauled in front of a Congressional subcommittee in May and grilled about corporate tax avoidance. At issue is a complex corporate structure that allows Apple’s European subsidiaries to distribute profits to a holding company in Ireland where the corporate tax rate is 12.5 percent. As a result, Apple holds over $100 billion in Ireland that the CEO says “isn’t coming back” anytime soon. This equates to avoiding $35 billion in […]

Read More →

This Week in Logistics News (June 24-28, 2013)

Another crazy Friday morning, now with the kids out of school, so let’s go straight to this week’s news: JDA Announces Major Enhancements to Workforce Mobility, All-Channel Commerce Solutions HighJump Software Enhances HighJump Warehouse Advantage Express Offering to Meet Increased Demand in SMB Marketplace FedEx Adds 1,900 New Lightweight, Fuel Efficient Vehicles to Fleet UPS Launches Industry-First Service For High-Value Time- And Temperature-Sensitive Shipments ATA Releases Latest Freight Forecast, Projecting Strong Trucking Growth Trucks Transported […]

Read More →

Supply Chain Integrity is Not Discussed Publicly

There are certain supply chain topics that are rarely discussed publicly. “Supply chain integrity” is one of them. Companies don’t want to admit that their products are being counterfeited, or that theft and grey market diversions are hurting profitability. They also don’t want thieves to know about the security measures they are taking to protect their products. At the Supply Chain Integrity track at ARC’s forum earlier this month, we conducted a think tank session […]

Read More →

Sustainability Initiatives at GlaxoSmithKline

The Fifth Annual Global Pharma Manufacturing Summit, organized by WTG, was held in Boson this past June. James Hagan, Vice President of Sustainability and Environment at GlaxoSmithKline (GSK) gave a presentation on “Strategies for Environmentally Sustainable Manufacturing.” My colleague Janice Abel attended the presentation and interviewed Mr. Hagan afterwards, which was the basis for a report she wrote on GSK’s holistic, multipronged approach to sustainability (the report is available to ARC clients only). Some of […]

Read More →

Preventing Counterfeiting in the Pharmaceutical Industry

When supply chain folks think about anti-counterfeiting in the pharmaceutical supply chain, we naturally think about bar codes and RFID. Those technologies have a role to play, but the requirements go far beyond the simple tracking that occurs in many other supply chains.    My colleagues Janice Abel and John Blanchard have written an ARC Insight (available to ARC clients only) on preventing counterfeiting in the pharmaceutical industry that documents the breadth of this problem, outlines […]

Read More →